Wegovy tablets are a once-daily weight-management medicine containing oral semaglutide, approved by the MHRA on 11 June 2026 as the first GLP-1 tablet for weight loss in the UK. They are licensed for adults with a BMI of 30 or above, or a BMI of 27–30 with at least one weight-related health condition, alongside a reduced-calorie diet and more physical activity. The tablet is taken on an empty stomach with a sip of water, with nothing else by mouth for 30 minutes. They are prescription-only and are not currently available on the NHS.
If you have been following the weight-loss injections story, you will have noticed a new question popping up everywhere: can I just take a tablet instead?
As of 2026, the answer in the UK is yes — for some people. Wegovy tablets bring the same active ingredient found in the well-known Wegovy injection into a pill you swallow each morning. For anyone who dislikes needles, travels a lot, or simply finds a daily tablet easier to fit into their routine, that is a meaningful change.
It is not a magic pill, and it is not right for everyone. This guide explains what Wegovy tablets actually are, how they are taken (there is one rule that catches people out), what the research shows, what side effects to plan for, and how to find out whether they might be suitable for you.
Wegovy tablets are a prescription-only weight-management medicine containing semaglutide in tablet form. They belong to a group of medicines called GLP-1 receptor agonists, which act on the same appetite pathways as a hormone your body already makes.
Semaglutide is not new — it has been used in the UK for several years as a weekly injection for weight management, and in tablet form for type 2 diabetes. What changed in June 2026 is that the MHRA approved a higher-strength daily tablet specifically for weight loss and weight management, making it the first GLP-1 tablet of its kind licensed in the UK.
| At a glance | Wegovy tablets |
|---|---|
| Active ingredient | Semaglutide (oral) |
| Medicine class | GLP-1 receptor agonist |
| Format | Tablet, swallowed whole |
| How often | Once daily |
| Licensed for | Weight loss and weight management in adults |
| BMI criteria | BMI ≥ 30, or BMI 27–30 with at least one weight-related condition |
| Tablet strengths | 1.5 mg, 4 mg, 9 mg, 25 mg |
| UK approval | MHRA, 11 June 2026 |
| Availability | Prescription-only; private prescription. Not currently available on the NHS |
Wegovy tablets work by mimicking GLP-1, a hormone released in your gut after eating that helps tell your brain you have had enough. By activating the same receptors, semaglutide can reduce appetite and help you feel fuller for longer, which makes it easier to eat less without constantly fighting hunger.
In practical terms, most people describe three changes:
Semaglutide also slows how quickly food leaves the stomach. That contributes to fullness, and it also explains most of the common side effects, which we cover further down.
Semaglutide is a peptide, and peptides are normally broken down in the stomach. Oral semaglutide is formulated with an absorption enhancer so that enough of it can be absorbed from a tablet. That is exactly why the "empty stomach, plain water, wait 30 minutes" rule matters so much — food and other drinks genuinely reduce how much medicine gets into your system.
Yes. Wegovy tablets were approved by the MHRA on 11 June 2026 and became available in the UK on private prescription through registered pharmacies and online doctor services. They are not currently available on the NHS — decisions on NHS use follow the established process, including an evaluation by NICE.
Because this is a prescription-only medicine, you cannot buy it over the counter or from a general online retailer. Every legitimate supply route in the UK involves a clinical assessment by a prescriber, followed by dispensing from a registered pharmacy.
Counterfeit weight-loss medicines are a real and growing problem. If a website offers Wegovy tablets without any consultation, without a named prescriber, or at a price that looks too good to be true, treat it as a warning sign. You can check whether a UK pharmacy is legitimate using the GPhC register.
Wegovy tablets are supplied privately, so the cost depends on the strength you are prescribed. Our current pricing is:
| Strength | Pack size | Price |
|---|---|---|
| Wegovy (semaglutide) 1.5 mg oral tablets | 30 tablets | £99.00 |
| Wegovy (semaglutide) 4 mg oral tablets | 30 tablets | £119.00 |
| Wegovy (semaglutide) 9 mg oral tablets | 30 tablets | £129.00 |
| Wegovy (semaglutide) 25 mg oral tablets | 30 tablets | £179.00 |
A 30-tablet pack covers one month of once-daily treatment. Because the dose is stepped up gradually, most people start on the lowest strength and move up only if their prescriber advises it.
Wegovy tablets are licensed for adults with a BMI of 30 or above, or a BMI between 27 and 30 with at least one weight-related health condition, used together with a reduced-calorie diet and increased physical activity.
Weight-related conditions that may be taken into account include:
Meeting the BMI criteria is a starting point, not an automatic yes. A prescriber will also look at your medical history, current medicines, previous experience with weight-loss treatment and what you are hoping to achieve. Some people are better suited to a different medicine, and some are better served by a non-medicine approach first.
BMI is a blunt instrument. It does not distinguish muscle from fat, and it can read differently across ethnic groups — lower BMI thresholds are often applied for people of South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean family background, because health risks can appear at a lower BMI. Your prescriber will take this into account.
Wegovy tablets are not suitable for everyone, and some people should not take them at all. Treatment is generally not appropriate if you:
Extra care, additional checks or a different treatment may be needed if you have:
This is a summary, not the full list. Always read the patient information leaflet supplied with your medicine and be completely open with your prescriber about your medical history — including anything you would rather not mention. It genuinely changes the advice you get.
Take one Wegovy tablet once a day, first thing in the morning, after fasting for at least 8 hours, swallowed whole with a sip of plain water. Wait at least 30 minutes before eating, drinking anything else, or taking other oral medicines.
Here is the routine that works for most people:
This is the single most common thing people get wrong. Taking the tablet with breakfast, or with a cup of tea, can substantially reduce how much medicine is absorbed — which may leave you thinking the treatment "isn't working" when the issue is timing. If mornings are chaotic, tell your prescriber; it is worth planning around before you start.
The dose is increased gradually. This is deliberate: it gives your digestive system time to adjust and helps reduce nausea.
| Step | Daily dose | Minimum time before increasing |
|---|---|---|
| Starting dose | 1.5 mg | At least 1 month |
| Step 2 | 4 mg | At least 1 month |
| Step 3 | 9 mg | At least 1 month |
| Step 4 (maintenance) | 25 mg | — |
Not everyone reaches 25 mg, and not everyone needs to. If you are doing well on a lower dose with manageable side effects, staying there can be the right clinical decision.
Most people notice appetite changes within the first few weeks, but meaningful weight change is usually assessed over months rather than weeks. The starting dose is intentionally low, so the early weeks are mainly about tolerating the medicine, not about the scales.
A realistic timeline looks something like this:
| Timeframe | What people often notice |
|---|---|
| Weeks 1–4 | Reduced appetite; possible nausea or changes in bowel habit as the body adjusts |
| Weeks 4–12 | Dose increases; appetite effects typically become more noticeable; early weight change |
| Months 3–6 | Steadier, more visible progress; habits around food and activity start to embed |
| Months 6–12+ | Continued change for many people, then a plateau; focus shifts to maintenance |
The main study behind this dose is the OASIS 4 trial, published in the New England Journal of Medicine in 2025. It compared once-daily oral semaglutide 25 mg with a placebo in 307 adults with overweight or obesity, without diabetes, alongside lifestyle support.
Trial averages are not promises. They come from a selected group of participants who received structured lifestyle support and close monitoring. Some people lose considerably more than the average, some lose less, and a minority do not respond well enough to justify continuing. Your own result will depend on your starting point, your health, the dose you tolerate, and the changes you are able to make alongside the medicine.
The most common side effects are digestive: nausea, diarrhoea, constipation and vomiting. They are usually most noticeable in the first weeks and after each dose increase, and for most people they ease as the body adapts.
Contact a healthcare professional promptly if you experience:
You can report suspected side effects directly through the MHRA Yellow Card scheme. Doing so helps improve safety information for everyone. Please also tell your Ready Health prescriber so we can adjust your care.
Because Wegovy tablets slow stomach emptying and must be taken on an empty stomach, they can affect how other medicines are absorbed. Tell your prescriber about everything you take, including over-the-counter products, supplements and herbal remedies.
Particular care is needed with:
Tell your surgical and anaesthetic team that you are taking a GLP-1 medicine well in advance of any planned operation, endoscopy or procedure involving sedation. Because the stomach empties more slowly, they may want to change your fasting instructions or pause treatment.
Both contain semaglutide and act on the same appetite pathway. The main differences are how often you take them, how you take them, and how strict the routine is.
| Wegovy tablets | Wegovy injection | |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide |
| How it is taken | Tablet, swallowed whole | Injection under the skin, using a pen |
| How often | Once a day | Once a week |
| Timing rules | Empty stomach, plain water, 30-minute wait | Any time of day, with or without food |
| Needles | None | Yes (very fine needle) |
| Storage | Room temperature | Refrigeration usually required before first use |
| Travel | Straightforward | Needs planning for cold storage |
| Main appeal | Needle-free, familiar tablet routine | Once a week, no daily timing rules |
Yes — the MHRA approval states that people already on the 2.4 mg weekly Wegovy injection can move directly to the 25 mg daily tablet, without repeating the dose build-up. This must be planned with your prescriber so the timing of your last injection and first tablet is handled properly.
Switching in the other direction, or switching from a different weight-loss medicine, is also possible in many cases but needs an individual assessment.
If you miss a dose of Wegovy tablets, skip it and take your next tablet at the usual time the following morning. Do not take two tablets to make up for a missed one.
Because of the fasting requirement, there is no realistic way to "catch up" later in the day — once you have eaten or had a drink other than water, absorption will be affected. Missing the occasional dose is not a crisis, but if you are missing several, tell us. Sometimes a different medicine or a different routine fits your life better.
If you miss more than a couple of weeks of treatment, get in touch before restarting. Tolerance to the medicine can fade, and you may need to step back down to a lower dose to avoid a rough return.
An online weight-management consultation is a clinical assessment, not a shopping basket. A prescriber reviews your information and decides whether treatment is appropriate — and sometimes the answer is no, or not yet.
We would always encourage you to let your GP know you are taking a weight-management medicine, so your records are complete and your care joins up.
Weight-management medication works best as part of ongoing care rather than a one-off purchase. Monitoring usually includes:
Your prescriber will agree a review schedule with you. If your response is limited despite good adherence, that is important information — not a personal failure — and there are other options to consider.
Wegovy tablets are licensed for use alongside a reduced-calorie diet and increased physical activity, and this is not a formality. The medicine makes eating less feel achievable; what you do with that window determines how well things go longer term.
Research on GLP-1 medicines consistently shows that weight tends to return when treatment stops, particularly if habits have not changed. It is worth discussing your longer-term plan with your prescriber early rather than at the point you want to stop.
Wegovy tablets are a prescription-only weight-management medicine containing oral semaglutide, a GLP-1 receptor agonist. Approved by the MHRA in June 2026, they are the first GLP-1 tablet licensed for weight loss in the UK. They are taken once daily on an empty stomach, alongside a reduced-calorie diet and increased physical activity.
In the OASIS 4 trial, adults taking oral semaglutide 25 mg lost an average of around 14% of their body weight over 64 weeks, compared with around 2% on placebo. That is an average from a clinical trial with structured support — individual results vary, and the medicine works best combined with diet and activity changes.
They mimic GLP-1, a hormone your gut releases after eating. By acting on GLP-1 receptors, semaglutide reduces appetite, helps you feel full sooner and slows how quickly food leaves the stomach. Most people find it easier to eat smaller portions without constant hunger.
Yes. The MHRA approved Wegovy tablets on 11 June 2026 and they are available in the UK on private prescription through registered pharmacies and online doctor services. They are not currently available on the NHS; NHS decisions follow the usual process, including a NICE evaluation.
Both contain semaglutide and act the same way. The tablet is taken daily on an empty stomach with a 30-minute wait before eating; the injection is weekly with no timing rules but requires a needle and usually refrigeration. The tablet suits people who prefer to avoid injections; the injection suits people who prefer a once-weekly routine.
Not currently. The MHRA has approved the medicine, but NHS funding is a separate decision made through established processes including evaluation by NICE. Until then, Wegovy tablets are accessed privately through a registered pharmacy following a clinical assessment.
At Ready Health, Wegovy 1.5 mg oral tablets (30 tablets) are £99.00, the 4 mg strength is £119.00, the 9 mg strength is £129.00 and the 25 mg strength is £179.00. Each pack covers one month. Prices include your consultation, pharmacist checks and delivery, and are correct at the time of publication.
Semaglutide is a peptide and is poorly absorbed from the gut. The tablet is formulated to improve absorption, but food and drink significantly reduce how much gets into your bloodstream. Fasting for at least 8 hours, taking it with a sip of plain water, and waiting 30 minutes before anything else gives the medicine the best chance to work.
No. Take the tablet with plain water only, and wait at least 30 minutes before tea, coffee, juice or any other drink. Taking it with anything other than water can reduce absorption and make the treatment less effective.
The most common are digestive: nausea, diarrhoea, constipation, vomiting, indigestion and stomach pain. They are usually mild to moderate, most noticeable early on and after dose increases, and often settle with time. Rarer but more serious effects include pancreatitis and gallbladder problems — seek medical advice for severe or persistent stomach pain.
Many people notice reduced appetite within the first few weeks, but the starting dose is deliberately low, so early weight change is usually modest. Meaningful progress is generally assessed over three to six months as the dose is increased. Weight loss is not linear, and plateaus are normal.
Often yes, but timing and monitoring matter. Because the tablet requires a 30-minute gap before anything else by mouth, other oral medicines need scheduling around it. Extra care is needed with insulin, sulfonylureas, levothyroxine and warfarin. Always give your prescriber a full list of what you take.
Skip the missed dose and take your next tablet at the usual time the following morning. Never double up. If you have missed more than a couple of weeks, contact your prescriber before restarting — you may need to go back to a lower dose.
In many cases, yes. The MHRA approval states that people on the 2.4 mg weekly injection can switch directly to the 25 mg daily tablet without repeating the dose build-up. The switch should be planned with your prescriber so the timing works correctly.
Some weight regain is common after stopping any GLP-1 medicine, particularly if eating and activity habits have not changed. This is why treatment is provided alongside dietary and lifestyle support, and why it is worth planning your longer-term approach with your prescriber well before you intend to stop.
No. Weight-management medicines including semaglutide are not suitable during pregnancy or breastfeeding, or if you are trying to conceive. If you become pregnant while taking Wegovy tablets, stop the medicine and speak to a healthcare professional promptly.
Wegovy tablets have been assessed by the MHRA, which judged the benefits to outweigh the risks for the licensed group of patients, and safety is monitored on an ongoing basis. Like all medicines they carry risks, they are not suitable for everyone, and they should only be taken following a clinical assessment and with appropriate follow-up.
Get in touch with your prescriber, GP or pharmacist if:
If you have chest pain, difficulty breathing, swelling of the face or throat, or severe abdominal pain, seek urgent medical help — call 999 or go to A&E. For non-urgent concerns, NHS 111 is available around the clock.
The only way to know is a proper clinical assessment. Our online consultation takes a few minutes, is reviewed by a UK-registered prescriber, and will tell you honestly whether this treatment is suitable — or whether something else would serve you better.
No obligation. If treatment is not appropriate for you, we will tell you why and suggest what to do instead.Medical disclaimer: This article is for general information and does not replace personalised medical advice. Wegovy tablets are a prescription-only medicine and are not suitable for everyone. Always read the patient information leaflet supplied with your medicine, and speak to a qualified healthcare professional about your own circumstances.